SR ONE CAPITAL MANAGEMENT LLC 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 8:14 pm Sale | 2023-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR | SR ONE CAPITAL MANAGEMENT LLC | 0 0.000% | -272,885 (Position Closed) | Filing |
| 2022-02-11 8:35 pm Purchase | 2021-12-31 | 13G | eFFECTOR Therapeutics, Inc. EFTR | SR ONE CAPITAL MANAGEMENT LLC | 272,885 16.900% | 272,885 (New Position) | Filing |